Combining Obesity Pharmacotherapy with Endoscopic Bariatric and Metabolic Therapies

Abstract Endoscopic Bariatric and Metabolic Therapies (EBMT) are rarely used in the United States. Compared with EBMTs alone, combining EBMTs with obesity pharmacotherapy may increase the magnitude and durability of weight loss and ultimately may contribute to increased patient satisfaction and EBMT utilization. Though combination therapy is frequently used in clinical practice, few published studies of combination EBMT/pharmacotherapy are available. Available studies and abstracts suggest that combination strategies are promising, but further research and clinical trials are needed. This article will review available obesity pharmacotherapy options and describe current data on combining EBMT and pharmacotherapy.